Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04056208 · ClinicalTrials.gov registry record · Phase 2

Pistachios Blood Sugar Control, Heart and Gut Health

A Phase 2 study of Type 2 Diabetes and Cardiovascular Diseases, sponsored by Penn State University.

Completed
Registry status
Phase 2
Development phase
66
Enrollment target
1
Study location

NCT04056208: Completed Phase 2 study of Type 2 Diabetes and Cardiovascular Diseases, sponsored by Penn State University.

NCT04056208 is a Phase 2 study of Type 2 Diabetes and Cardiovascular Diseases that has completed, run by Penn State University. The registered enrollment target is 66 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04056208, a Phase 2 study of Type 2 Diabetes and Cardiovascular Diseases, has completed, sponsored by Penn State University.

COMPLETED
Registry status
Phase 2
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

A two-period randomized crossover study will be conducted to evaluate the effect of nighttime pistachio consumption (i.e., after dinner and before sleep) on fasting blood sugar levels, longer-term blood sugar control, and risk factors for heart disease. This study will also investigate how pistachios affects gut health.

Primary Outcome

Fasting blood glucose (mg/dL)

Conditions Studied

Type 2 Diabetes Cardiovascular Diseases

Interventions

  • OTHER Usual care
  • DRUG Pistachio

Study Locations (1)

Pennsylvania

  • Pennsylvania State University - University Park

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2019-09-09
Est. Completion 2022-11-17
Phase Phase 2
Penn State University

219 total trials

What the finished NCT04056208 record still lists

NCT04056208 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.

NCT04056208 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04056208 about?

NCT04056208 is a clinical study titled "Pistachios Blood Sugar Control, Heart and Gut Health". A two-period randomized crossover study will be conducted to evaluate the effect of nighttime pistachio consumption (i.e., after dinner and before sleep) on fasting blood sugar levels, longer-term blood sugar control, and risk factors for heart disease. This study will also investigate how pistachio...

What is the current status of trial NCT04056208?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2019-09-09. Estimated completion is 2022-11-17.

What conditions does trial NCT04056208 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Cardiovascular Diseases.

What interventions are being tested in trial NCT04056208?

The interventions under investigation include: Usual care (OTHER), Pistachio (DRUG).

Who is sponsoring clinical trial NCT04056208?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04056208 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04056208's enrollment target sits among peer trials

66 189th of 327 higher than 139 of 327 other Type 2 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04056208, the US trial registry maintained by the National Library of Medicine. NCT04056208 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.